CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 450 enrolled
Drug / intervention
Offering a financial incentive to increase walkingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03037658
NCT03037658N/ACompleted

Physical Activity Incentives

Stanford University·interventional·Posted Jan 31, 2017·Updated Apr 24, 2026

In Brief

A clinical study evaluating Offering a financial incentive to increase walking for Physical Activity. Completed, enrolled 450 participants across 1 site.

Detailed Summary

In this study, the investigators will test responsiveness of young, middle-aged, and older adults to a range of incentives, some of which provide rewards for the individual participants and others that offer rewards to other people or groups. The investigators hypothesize that incentives are differentially effective for different age groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 31, 2017
Enrollment StartSep 1, 2013
Primary CompletionMar 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 9.4 years ago

Interventions

Offering a financial incentive to increase walkingother

After a baseline week of walking while wearing a pedometer, participants will be randomly assigned to one of the five conditions. In each of these conditions, participants will have the chance to earn .02/step for each additional step per day (on average across the week, above baseline levels). After a week of incentivized walking, participants will again be asked to wear the pedometer for one final week (with no incentive). Because the investigators need a week of walking before the incentive week, it is important that participants do not know the specific incentive aspect at the beginning of the study. Therefore, the investigators will not disclose the incentive structure at the beginning of the study. The investigators will debrief participants at the end of the study, and they will be fully informed of the purposes of the study at that time.